Search

Your search keyword '"Butzow R"' showing total 273 results

Search Constraints

Start Over You searched for: Author "Butzow R" Remove constraint Author: "Butzow R"
273 results on '"Butzow R"'

Search Results

1. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk

2. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

3. Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers.

4. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

5. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk.

6. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci

7. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci

8. Low expression of stanniocalcin 1 (STC-1) protein is associated with poor clinicopathologic features of endometrial cancer

9. Uterine leiomyomas in hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome can be identified through distinct clinical characteristics and typical morphology

10. Shared heritability and functional enrichment across six solid cancers (vol 10, 431, 2019)

11. Shared heritability and functional enrichment across six solid cancers.

12. Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4).

13. Erratum: Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature communications (2019) 10 1 (431))

14. Shared heritability and functional enrichment across six solid cancers

15. Shared heritability and functional enrichment across six solid cancers (vol 10, 431, 2019)

16. Shared heritability and functional enrichment across six solid cancers

17. Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4)

18. A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk

19. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility

20. Adult height is associated with increased risk of ovarian cancer: A Mendelian randomisation study

21. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology

22. Adult height is associated with increased risk of ovarian cancer: A Mendelian randomisation study

23. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology

24. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

25. Risk of Ovarian Cancer and the NF-? B Pathway: Genetic Association with IL1A and TNFSF10

26. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

27. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci

28. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

29. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci

30. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

31. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

32. BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers

33. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: Results from a large-scale collaboration

34. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

35. PALB2, CHEK2 and ATM rare variants and cancer risk:data from COGS

36. Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer

37. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer

38. Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci

39. Common genetic variation in cellular transport genes and epithelial ovarian cancer (EOC) risk

40. Genome-wide significant risk associations for mucinous ovarian carcinoma

41. Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk

42. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

43. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

44. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes

45. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study

46. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

47. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration

48. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

49. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

50. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

Catalog

Books, media, physical & digital resources